Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis.
Shuichi SuetaniDan J SiskindAndrea PhillipouAnna WaterreusVera Anne MorganDavid CastlePublished in: The Australian and New Zealand journal of psychiatry (2021)
Long-acting injectable use in Australia is associated with higher rates of community treatment order use, as well as poorer insight, personal and social performance, and greater cognitive impairment. While long-acting injectables may have the potential to improve the prognosis of people with psychosis, a better understanding of the choices behind the utilisation of long-acting injectable treatment in Australia is urgently needed.